Literature DB >> 7463697

Systemic lupus erythematosus--survival patterns. Experience with 609 patients.

D J Wallace, T Podell, J Weiner, J R Klinenberg, S Forouzesh, E L Dubois.   

Abstract

Six hundred nine private patients with systemic lupus erythematosus were followed up for a mean of ten years. Ninety percent were female; 79% were white. Three hundred sixty-nine received diagnosis before 1970, and 234 after. Three hundred seventy-nine did not have nephritis; 230 did. The overall ten-year survival was 79% (87% without nephritis, 65% with nephritis). Male patients did consistently worse than female patients. No overall white vs nonwhite difference was noted. The presence of nephrotic syndrome at the onset of nephritis was a poor prognostic sign, but its development later was not. Patients younger than 16 years without nephritis have an excellent prognosis. One hundred twenty-eight patients died (82 with nephritis, 46 without nephritis). The most common causes of death were renal disease and sepsis. Improved survival of this series may reflect closer follow-up, better nutritional status, and treatment at earlier stages of disease.

Entities:  

Mesh:

Year:  1981        PMID: 7463697     DOI: 10.1001/jama.245.9.934

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  42 in total

Review 1.  Outcome and survival in systemic lupus erythematosus.

Authors:  B Bresnihan
Journal:  Ann Rheum Dis       Date:  1989-06       Impact factor: 19.103

Review 2.  Infection-related morbidity and mortality in patients with connective tissue diseases: a systematic review.

Authors:  Matthew E Falagas; Katerina G Manta; Gregoria I Betsi; Georgios Pappas
Journal:  Clin Rheumatol       Date:  2006-12-21       Impact factor: 2.980

3.  Assessment of the effect of oral corticosteroids on bone mineral density in systemic lupus erythematosus: a preliminary study with dual energy x ray absorptiometry.

Authors:  V B Dhillon; M C Davies; M L Hall; J M Round; P J Ell; H S Jacobs; M L Snaith; D A Isenberg
Journal:  Ann Rheum Dis       Date:  1990-08       Impact factor: 19.103

4.  EULAR randomised controlled trial of pulse cyclophosphamide and methylprednisolone versus continuous cyclophosphamide and prednisolone followed by azathioprine and prednisolone in lupus nephritis.

Authors:  C-S Yee; C Gordon; C Dostal; P Petera; J Dadoniene; B Griffiths; B Rozman; D A Isenberg; G Sturfelt; O Nived; J H Turney; A Venalis; D Adu; J S Smolen; P Emery
Journal:  Ann Rheum Dis       Date:  2004-05       Impact factor: 19.103

5.  Childhood lupus nephritis: 12 years experience from North India.

Authors:  Surjit Singh; Ranjana Minz; Ritambhra Nada; Kusum Joshi
Journal:  Rheumatol Int       Date:  2006-05       Impact factor: 2.631

6.  Systemic lupus erythematosus in Saudi patients.

Authors:  S R Alballa
Journal:  Clin Rheumatol       Date:  1995-05       Impact factor: 2.980

7.  Expression of systemic lupus erythematosus in various ethnic Jewish Israeli groups.

Authors:  A J Wysenbeek; L Leibovici; A Weinberger; D Guedj
Journal:  Ann Rheum Dis       Date:  1993-04       Impact factor: 19.103

8.  Fatal infection in children with lupus nephritis treated with intravenous cyclophosphamide.

Authors:  Kamolwish Laoprasopwattana; Pornsak Dissaneewate; Prayong Vachvanichsanong
Journal:  Pediatr Nephrol       Date:  2009-03-12       Impact factor: 3.714

Review 9.  Review: Male systemic lupus erythematosus: a review of sex disparities in this disease.

Authors:  L-J Lu; D J Wallace; M L Ishimori; R H Scofield; M H Weisman
Journal:  Lupus       Date:  2009-11-27       Impact factor: 2.911

10.  Blood rheology in lupus erythematosus.

Authors:  E Ernst; A Hein; M Meurer; T Ruzicka
Journal:  Ann Rheum Dis       Date:  1991-10       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.